How do you recommend that clinicians directly and immediately apply the results of the CV outcome trials with alirocumab and evolocumab directly to the front lines of medical cardiology practice?

How do you recommend that clinicians directly and immediately apply the results of the CV outcome trials with alirocumab and evolocumab directly to the front lines of medical cardiology practice?

How do you recommend that clinicians directly and immediately apply the results of the CV outcome trials with alirocumab and evolocumab directly to the front lines of medical cardiology practice?


Created by

CMEducation Resources IQ&A Cardiovascular Intelligence Zone | The Medical Cardiology, Interventional Cardiology, Lipid Medicine, Atherosclerosis and Diabetes Specialist's Perspective

Presenter

R. Scott Wright, MD

R. Scott Wright, MD

Professor of Medicine Department of Cardiovascular Medicine Cardiovascular Division Mayo Clinic